Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease.
Ontology highlight
ABSTRACT: Adenosine to inosine (A-to-I) RNA editing, catalyzed by the ADAR enzyme family, acts on dsRNA structures within pre-mRNA molecules. Editing of the coding part of the mRNA may lead to recoding, amino acid substitution in the resulting protein, possibly modifying its biochemical and biophysical properties. Altered RNA editing patterns have been observed in various neurological pathologies. Here, we present a comprehensive study of recoding by RNA editing in Alzheimer's disease (AD), the most common cause of irreversible dementia. We have used a targeted resequencing approach supplemented by a microfluidic-based high-throughput PCR coupled with next-generation sequencing to accurately quantify A-to-I RNA editing levels in a preselected set of target sites, mostly located within the coding seq
SUBMITTER: Khermesh K
PROVIDER: S-EPMC4712678 | biostudies-literature | 2016 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA